PECAM1 and prostate neoplasm: In a study of orthotopic and subcutaneously implanted Myc-CaP prostate tumors in mice, Kalmuk et al. noted a significant reduction of CD31+ vascular endothelial cell clusters and microvessel counts in tumors from crolibulin-treated mice compared to control tumors.